Tanishq Kumar

Department of Pharmacology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed to be University), Sawangi (Meghe), Wardha, Maharashtra, India


  • Research   
    Role of Rosuvastatin in Treating Diabetes Mellitus, Heart Failure and Hyper Cholesterolemia
    Author(s): Tanishq Kumar* and Benumadhab Ghosh

    Rosuvastatin is another age HMG-CoA reductase inhibitor exhibiting interesting therapeutic and pharmacodynamics characteristics. It consists of a limited extra hepatic tissue perfusion, a low potential for CYP3A4 connections, and a significant LDL-C lowering limit, and hence has undeniable advantages. In this review article, we explore the pharmacological aspects of rosuvastatin, highlighting its reliability. We also examine the significant medical investigations involving hereditary hypercholesterolemia and its association to various statins. Ultimately, we will address its role in clinical treatment. Coronary illness (CHD) is the main source of death around the world. The viability and security of statins in essential and optional avoidance of CHD is affirmed in a few enormous investigations. The most notable statin to hit the market is rosuvastatin. It is observed that 5-20 mg/day .. Read More»

    Abstract HTML PDF